Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Pfizer
ViiV Healthcare
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01276236
First received: December 20, 2010
Last updated: July 23, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)